Agios Pharmaceuticals
Stock Forecast, Prediction & Price Target

Agios Pharmaceuticals (AGIO) stock Price Target by analysts

Last Year
Average Price Target

$54.33

Potential upside: 50.00%

Based on 3 analysts

Agios Pharmaceuticals price prediction

Strike.market

What is Agios Pharmaceuticals stock analysts` prediction?

Agios Pharmaceuticals stock forecast: Based on 3 Wall Street analysts` predicted price targets for Agios Pharmaceuticals in the last 3 months, the avarage price target is $54.33, with a high forecast of $NaN. The average price target represents a 50.00% change from the last price of $36.22.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Agios Pharmaceuticals stock Price Target by analysts

Full breakdown of analysts given Agios Pharmaceuticals price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Danielle Brill
Raymond James
0%
0/1
10 months ago $51 40.80% upside $44.43 StreetInsider
Previous targets (0)
Andrew Berens
Leerink Partners
0%
0/1
11 months ago $56 54.61% upside $45.61 StreetInsider
Previous targets (0)
Chris Raymond
Raymond James
0%
0/3
12 months ago $56 54.61% upside $44.05 StreetInsider
Previous targets (2)
Chris Raymond
Raymond James
0%
0/3
about 1 year ago $55 51.84% upside $43.42 StreetInsider
Previous targets (2)
Gregory Renza
RBC Capital
0%
0/1
over 1 year ago $53 46.32% upside $44.26 TheFly
Previous targets (0)
Chris Raymond
Raymond James
0%
0/3
over 1 year ago $45 24.24% upside $38.39 StreetInsider
Previous targets (2)
Unknown
Piper Sandler
N/A
over 2 years ago $41 13.19% upside $30.18 Benzinga
N/A
Unknown
J.P. Morgan
N/A
almost 3 years ago $33 -8.89% downside $29.46 Benzinga
N/A
Unknown
Goldman Sachs
N/A
almost 3 years ago $32 -11.65% downside $27.13 Benzinga
N/A
Peter Lawson
Barclays
0%
0/1
over 4 years ago $70 93.26% upside $55.8 TheFly
Previous targets (0)

Agios Pharmaceuticals Financial Estimates

Agios Pharmaceuticals Revenue Estimates

Agios Pharmaceuticals EBITDA Estimates

Agios Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$14.24M
 
0%
$26.82M
 
88.36%
Avg: $124.92M
Low: $80.17M
High: $202.02M
avg. 365.75%
Avg: $220.99M
Low: $139.37M
High: $388.44M
avg. 76.89%
Avg: $375.64M
Low: $236.90M
High: $660.26M
avg. 69.97%
Avg: $562.84M
Low: $354.97M
High: $989.31M
avg. 49.83%
Net Income
 
% change YoY
$1.60B
 
N/A
$-74.55M
 
-104.64%
$-352.08M
 
-372.25%
Avg: $-342.08M
Low: $-382.32M
High: $-174.74M
avg. 2.84%
Avg: $-286.18M
Low: $-399.57M
High: $-72.90M
avg. 16.34%
Avg: $-77.13M
Low: $-153.11M
High: $-40.09M
avg. 73.04%
Avg: $79.99M
Low: $41.59M
High: $158.79M
avg. 203.71%
EBITDA
 
% change YoY
$-385.05M
 
N/A
$-526.75M
 
-36.79%
$-384.86M
 
26.93%
Avg: $-74.95M
Low: $-121.21M
High: $-48.10M
avg. 80.52%
Avg: $-132.59M
Low: $-233.06M
High: $-83.62M
avg. -76.89%
Avg: $-225.38M
Low: $-396.16M
High: $-142.14M
avg. -69.97%
Avg: $-337.70M
Low: $-593.59M
High: $-212.98M
avg. -49.83%
EPS
 
% change YoY
$26.55
 
N/A
-$1.36
 
-105.12%
-$6.33
 
-365.44%
Avg: -$5.62
Low: -$6.87
High: -$3.14
avg. 11.20%
Avg: -$4.5
Low: -$7.18
High: -$1.31
avg. 19.90%
Avg: -$1.39
Low: -$2.75
High: -$0.72
avg. 69.21%
Avg: $1.44
Low: $0.75
High: $2.85
avg. 203.71%
Operating Expenses
 
% change YoY
$378.41M
 
N/A
$401.58M
 
6.12%
$408.80M
 
1.79%
Avg: $396.47M
Low: $254.45M
High: $641.15M
avg. -3.01%
Avg: $701.34M
Low: $442.32M
High: $1.23B
avg. 76.89%
Avg: $1.19B
Low: $751.85M
High: $2.09B
avg. 69.97%
Avg: $1.78B
Low: $1.12B
High: $3.13B
avg. 49.83%

FAQ

What is Agios Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 73.98% in 2025-2028.

We have gathered data from 7 analysts. Their low estimate is -382.32M, average is -342.08M and high is -174.74M.

What is Agios Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 140.61% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is $80.17M, average is $124.92M and high is $202.02M.

What is Agios Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 76.00% in 2025-2028.

We have gathered data from 7 analysts. Their low earnings per share estimate is -$6.87, average is -$5.62 and high is $-3.14.

What is the best performing analyst?

In the last twelve months 3 analysts have been covering Agios Pharmaceuticals stock. The most successful analyst is Danielle Brill.